Case Rep Gastroenterol 2015;9:266–271 DOI: 10.1159/000437290 Published online: July 29, 2015

© 2015 S. Karger AG, Basel 1662‒0631/15/0092‒0266$39.50/0 www.karger.com/crg

This is an Open Access article licensed under the terms of the Creative Commons Attribution-NonCommercial 3.0 Unported license (CC BY-NC) (www.karger.com/OAlicense), applicable to the online version of the article only. Distribution permitted for noncommercial purposes only.

Metastatic Fibrolamellar Hepatocellular Carcinoma to the Pancreas Nicolas A. Villaa Rahul Pannala a Douglas O. Faigela Danielle J. Haakinson b Nitin Katariya c Ramesh Ramanathan d Dawn Jaroszewski e Thomas K. Lidnerf Thomas Byrnea a

b

c

Division of Gastroenterology and Hepatology, Department of General Surgery, Division d e of Transplant Surgery, Division of Hematology and Oncology, Division of Cardiothoracic f Surgery, and Department of Pathology, Mayo Clinic Arizona, Scottsdale, Ariz., USA

Key Words Fibrolamellar hepatocellular carcinoma · Metastasis · Liver transplantation Abstract Fibrolamellar hepatocellular carcinoma (FL-HCC) is a rare variant of hepatocellular carcinoma, usually presenting in the younger population (